Ontology highlight
ABSTRACT: Background
Mesenchymal stem cells (MSCs) have been reported to possess immune regulatory effects in innate and adaptive immune reactions. MSCs can mediate intercellular communications by releasing extracellular vesicles (EVs), which deliver functional molecules to targeted cells. MSC derived EVs (MSC-EVs) confer altering effects on many immune cells, including T lymphocytes, B lymphocytes, natural killer cells, dendritic cells, and macrophages. A large number of studies have suggested that MSC-EVs participate in regulating autoimmunity related diseases. This characteristic of MSC-EVs makes them be potential biomarkers for the diagnosis and treatment of autoimmunity related diseases.Aim
To verify the potential of MSC-EVs for molecular targeted therapy of autoimmunity related
SUBMITTER: Wang JH
PROVIDER: S-EPMC7477661 | biostudies-literature | 2020 Aug
REPOSITORIES: biostudies-literature